CompetitiveWatch Cancer Diagnostics: Strategic Assessments of Major Suppliers

May 2013 | 80 pages | ID: C11E9A66336EN
Venture Planning Group

Abstracts

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 80 pages

Contents

Abbott
AdnaGen
Agensys
Altana
Ambrilia Biopharma
AMDL
BD
Beckman Coulter
Biofield
Biomedical Diagnostics
bioMerieux
Bio-Rad
Biotrol/B. Braun
CeMines
Cepheid
CIS/BIO
Cliniqa
Correlogic Systems
Cytyc
Daiichi
DakoCytomation
diaDexus
DiagnoCure
Diagnostic Systems
Dianon
DiaSorin
Digene
Eiken
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Gen-Probe
Gene Logic
Green Cross
Grifols-Quest
Guided Therapeutics
Ibex Technologies
Immunicon
Ipsogen
Kyowa Medex
Matritech
Molecular Diagnostics
Myriad Genetics
Nippon Flour Mills
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Quest Diagnostics Nichols Institute
Roche Diagnostics
Scantibodies
Siemens
Targeted Diagnostics
Tosoh
Trylon
Wako Chemicals
Worldwide Medical
Zila